Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,825,917
+$4,017,680 QoQ
Shares Held
121,088
+114.0% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 57.39049286469344.ToString("F0")%
Shared 0.ToString("F0")%
None 42.60950713530655.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. HALO ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in HALO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,825,917 | 121,088 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,808,237 | 56,586 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,534,107 | 48,188 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,553,869 | 49,094 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,206,230 | 34,575 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,427,702 | 29,862 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,375,648 | 24,033 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,380,366 | 26,363 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,087,986 | 26,745 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,014,773 | 27,456 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,008,594 | 26,403 | Shares | Sole | 2023-11-15 | |
| 2022-12-31 | $262,081 | 4,606 | Shares | Sole | 2023-02-15 | |
| 2022-06-30 | $171,688 | 3,902 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $134,555 | 3,374 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $130,561 | 3,247 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $117,890 | 2,898 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $117,384 | 2,585 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $107,893 | 2,588 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $83,498 | 1,955 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $44,676 | 1,700 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $45,577 | 1,700 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||